stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Aktis Oncology IncAKTS
$14.598.41%-1.34

Aktis Oncology Inc (AKTS)

Date: 2026-11-02 16:00O: 16.01H: 16.01L: 13.96C: 14.59Vol: 898.2k
Schlusskurs vom Vortag:
$15.93
Offen:
$16.01
24-Stunden-Volumen:
898,181
Relatives Volumen:
2.78
Marktkapitalisierung:
$811.49M
Einnahmen:
$7.48M
Nettoeinkommen (Verlust:
-$60.50M
KGV:
-
EPS:
-$1.13
Netto-Cashflow:
-$52.28M
1W Leistung:
-11.31%
1M Leistung:
-21.22%
6M Leistung:
-24.87%
1Y Leistung:
+39,120%
1-Tages-Spanne:
$0.00$0.00
1-Wochen-Bereich:
$13.96$17.33
52-Wochen-Spanne:
$0.033$34.19

Aktis Oncology Inc Aktie (AKTS) Unternehmensprofil

Firmenname
Aktis Oncology Inc
Telefon
978-237-4380
Adresse
17 DRYDOCK AVENUE, BOSTON, NC, USA
Mitarbeiter
79
Nächster Verdiensttermin
2026-11-12
Neueste SEC-Einreichungen
SEC
AKTS-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Aktis Oncology Inc Aktie (AKTS) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-09-09EingeleitetOppenheimerOutperform
2026-08-19EingeleitetBMO Capital MarketsOutperform
2026-08-19EingeleitetWedbushOutperform
2026-06-16EingeleitetRaymond JamesStrong Buy

Finanzdaten der Aktis Oncology Inc-Aktie (AKTS)

ZeitraumTrendFY 2023FY 2022FY 2021FY 2020FY 2019
Enddatum des Zeitraums-2022-06-302021-06-302020-06-302019-06-30
Revenue USD (M)27.1215.356.621.791.44
Cost of revenue USD (M)30.2419.4910.652.411.01
Gross profit USD (M)-3.12-4.14-4.03-0.620.43
Research and development USD (M)33.2435.7124.0820.5219.25
Operating expenses USD (M)62.9556.4237.3631.4128.00
Operating income USD (M)-66.07-60.56-41.39-32.04-27.57
Income before tax USD (M)-66.0115.35-44.161.791.44
Income tax expense USD (M)-2.45-1.83---
Net income USD (M)-63.56-59.19-44.16-36.14-29.25
Basic EPS USD/shares-1.00-1.09---
Diluted EPS USD/shares-1.00-1.09---
Basic weighted shares shares (M)63.6254.02---
Diluted weighted shares shares (M)63.6254.02---
Selling, general and administrative USD (M)29.71----

Aktis Oncology Inc-Aktie (AKTS) Insiderhandel

  • Czibere AkosSep 23 '26
    Chief Medical Officer
    Transaktion
    Option Exercise
    Kosten
    $4.95
    #Aktien
    12,500
    Wert ($)
    61,875
    #Aktien Gesamt
    12,500
  • Czibere AkosSep 23 '26
    Chief Medical Officer
    Transaktion
    Sale
    Kosten
    $20.69
    #Aktien
    12,500
    Wert ($)
    258,621
    #Aktien Gesamt
    0
  • Akos CzibereSep 23 '26
    Officer
    Transaktion
    Proposed Sale
    Kosten
    $22.11
    #Aktien
    25,000
    Wert ($)
    552,750
    #Aktien Gesamt
    0
  • Herrmann KenJul 20 '26
    Director
    Transaktion
    Sale
    Kosten
    $24.56
    #Aktien
    4,856
    Wert ($)
    119,274
    #Aktien Gesamt
    0
  • KEN HERRMANNJul 20 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $24.56
    #Aktien
    4,856
    Wert ($)
    119,275
    #Aktien Gesamt
    0
  • Herrmann KenJul 20 '26
    Director
    Transaktion
    Option Exercise
    Kosten
    $0.59
    #Aktien
    4,856
    Wert ($)
    2,859
    #Aktien Gesamt
    4,856
  • KEN HERRMANNJul 17 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $25.21
    #Aktien
    3,065
    Wert ($)
    77,259
    #Aktien Gesamt
    0
  • Herrmann KenJul 17 '26
    Director
    Transaktion
    Sale
    Kosten
    $25.21
    #Aktien
    3,065
    Wert ($)
    77,259
    #Aktien Gesamt
    0
  • Herrmann KenJul 17 '26
    Director
    Transaktion
    Option Exercise
    Kosten
    $0.08
    #Aktien
    3,065
    Wert ($)
    245
    #Aktien Gesamt
    3,065
  • Chief Operating Officer
    Transaktion
    Sale
    Kosten
    $27.75
    #Aktien
    50,000
    Wert ($)
    1,387,558
    #Aktien Gesamt
    0
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Czibere AkosChief Medical OfficerSep 23 '26Option Exercise$4.9512,50061,87512,500
Czibere AkosChief Medical OfficerSep 23 '26Sale$20.6912,500258,6210
Akos CzibereOfficerSep 23 '26Proposed Sale$22.1125,000552,7500
Herrmann KenDirectorJul 20 '26Sale$24.564,856119,2740
KEN HERRMANNDirectorJul 20 '26Proposed Sale$24.564,856119,2750
Herrmann KenDirectorJul 20 '26Option Exercise$0.594,8562,8594,856
KEN HERRMANNDirectorJul 17 '26Proposed Sale$25.213,06577,2590
Herrmann KenDirectorJul 17 '26Sale$25.213,06577,2590
Herrmann KenDirectorJul 17 '26Option Exercise$0.083,0652453,065
Ron-Bigger ShulamitChief Operating OfficerJul 08 '26Sale$27.7550,0001,387,5580

Aktis Oncology Inc Aktie (AKTS) Neueste Nachrichten

Oct 23, 2026
Oct 23, 2026
Oct 20, 2026
Oct 20, 2026
Oct 14, 2026
Oct 14, 2026
Oct 10, 2026
Oct 10, 2026
Sep 27, 2026
Sep 27, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 26, 2026
Sep 24, 2026
Sep 24, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 03, 2026
Sep 03, 2026
Aug 31, 2026
Aug 31, 2026
Aug 29, 2026
Aug 29, 2026
Aug 28, 2026
Aug 28, 2026
Aug 22, 2026
Aug 22, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 15, 2026
Aug 15, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 08, 2026
Aug 08, 2026

Ähnlich wie AKTS